These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 26453964)

  • 1. CNS remyelination as a novel reparative approach to neurodegenerative diseases: The roles of purinergic signaling and the P2Y-like receptor GPR17.
    Fumagalli M; Lecca D; Abbracchio MP
    Neuropharmacology; 2016 May; 104():82-93. PubMed ID: 26453964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal Upregulation of GPR17 Receptor Contributes to Oligodendrocyte Dysfunction in SOD1 G93A Mice.
    Bonfanti E; Bonifacino T; Raffaele S; Milanese M; Morgante E; Bonanno G; Abbracchio MP; Fumagalli M
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair.
    Lecca D; Trincavelli ML; Gelosa P; Sironi L; Ciana P; Fumagalli M; Villa G; Verderio C; Grumelli C; Guerrini U; Tremoli E; Rosa P; Cuboni S; Martini C; Buffo A; Cimino M; Abbracchio MP
    PLoS One; 2008; 3(10):e3579. PubMed ID: 18974869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UDP-glucose enhances outward K(+) currents necessary for cell differentiation and stimulates cell migration by activating the GPR17 receptor in oligodendrocyte precursors.
    Coppi E; Maraula G; Fumagalli M; Failli P; Cellai L; Bonfanti E; Mazzoni L; Coppini R; Abbracchio MP; Pedata F; Pugliese AM
    Glia; 2013 Jul; 61(7):1155-71. PubMed ID: 23640798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purinergic contribution to amyotrophic lateral sclerosis.
    Volonté C; Apolloni S; Parisi C; Amadio S
    Neuropharmacology; 2016 May; 104():180-93. PubMed ID: 26514402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation and signaling of the GPR17 receptor in oligodendroglial cells.
    Lecca D; Raffaele S; Abbracchio MP; Fumagalli M
    Glia; 2020 Oct; 68(10):1957-1967. PubMed ID: 32086854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential local tissue permissiveness influences the final fate of GPR17-expressing oligodendrocyte precursors in two distinct models of demyelination.
    Coppolino GT; Marangon D; Negri C; Menichetti G; Fumagalli M; Gelosa P; Dimou L; Furlan R; Lecca D; Abbracchio MP
    Glia; 2018 May; 66(5):1118-1130. PubMed ID: 29424466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G-Protein-Coupled Receptor Gpr17 Regulates Oligodendrocyte Differentiation in Response to Lysolecithin-Induced Demyelination.
    Lu C; Dong L; Zhou H; Li Q; Huang G; Bai SJ; Liao L
    Sci Rep; 2018 Mar; 8(1):4502. PubMed ID: 29540737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration.
    Burnstock G
    Neuropharmacology; 2016 May; 104():4-17. PubMed ID: 26056033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine A₂A receptors inhibit delayed rectifier potassium currents and cell differentiation in primary purified oligodendrocyte cultures.
    Coppi E; Cellai L; Maraula G; Pugliese AM; Pedata F
    Neuropharmacology; 2013 Oct; 73():301-10. PubMed ID: 23770463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olig2-Targeted G-Protein-Coupled Receptor Gpr17 Regulates Oligodendrocyte Survival in Response to Lysolecithin-Induced Demyelination.
    Ou Z; Sun Y; Lin L; You N; Liu X; Li H; Ma Y; Cao L; Han Y; Liu M; Deng Y; Yao L; Lu QR; Chen Y
    J Neurosci; 2016 Oct; 36(41):10560-10573. PubMed ID: 27733608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nerve impulses regulate myelination through purinergic signalling.
    Fields RD
    Novartis Found Symp; 2006; 276():148-58; discussion 158-61, 233-7, 275-81. PubMed ID: 16805428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the adenosinergic system in lung fibrosis.
    Della Latta V; Cabiati M; Rocchiccioli S; Del Ry S; Morales MA
    Pharmacol Res; 2013 Oct; 76():182-9. PubMed ID: 23994158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purinergic signalling in brain ischemia.
    Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
    Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the new P2Y-like receptor GPR17 during oligodendrocyte precursor cell maturation regulates sensitivity to ATP-induced death.
    Ceruti S; Viganò F; Boda E; Ferrario S; Magni G; Boccazzi M; Rosa P; Buffo A; Abbracchio MP
    Glia; 2011 Mar; 59(3):363-78. PubMed ID: 21264945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recently identified GPR17 receptors--characteristics and role in pathology of the nervous system].
    Wypych D
    Postepy Biochem; 2014; 60(4):514-24. PubMed ID: 25807830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological Properties and Biological Functions of the GPR17 Receptor, a Potential Target for Neuro-Regenerative Medicine.
    Fumagalli M; Lecca D; Coppolino GT; Parravicini C; Abbracchio MP
    Adv Exp Med Biol; 2017; 1051():169-192. PubMed ID: 28828731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue transglutaminase activity is involved in the differentiation of oligodendrocyte precursor cells into myelin-forming oligodendrocytes during CNS remyelination.
    Van Strien ME; Baron W; Bakker EN; Bauer J; Bol JG; Brevé JJ; Binnekade R; Van Der Laarse WJ; Drukarch B; Van Dam AM
    Glia; 2011 Nov; 59(11):1622-34. PubMed ID: 21818782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The G Protein-Coupled Receptor GPR17: Overview and Update.
    Marucci G; Dal Ben D; Lambertucci C; Santinelli C; Spinaci A; Thomas A; Volpini R; Buccioni M
    ChemMedChem; 2016 Dec; 11(23):2567-2574. PubMed ID: 27863043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new role for the P2Y-like GPR17 receptor in the modulation of multipotency of oligodendrocyte precursor cells in vitro.
    Boccazzi M; Lecca D; Marangon D; Guagnini F; Abbracchio MP; Ceruti S
    Purinergic Signal; 2016 Dec; 12(4):661-672. PubMed ID: 27544384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.